FI773568A - Farmaceutiska preparat med laongtidsverkan - Google Patents

Farmaceutiska preparat med laongtidsverkan

Info

Publication number
FI773568A
FI773568A FI773568A FI773568A FI773568A FI 773568 A FI773568 A FI 773568A FI 773568 A FI773568 A FI 773568A FI 773568 A FI773568 A FI 773568A FI 773568 A FI773568 A FI 773568A
Authority
FI
Finland
Prior art keywords
laongtidsverkan
med
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
FI773568A
Other languages
English (en)
Other versions
FI65910C (fi
FI65910B (fi
Inventor
Yegnaswami Raghunathan
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of FI773568A publication Critical patent/FI773568A/fi
Application granted granted Critical
Publication of FI65910B publication Critical patent/FI65910B/fi
Publication of FI65910C publication Critical patent/FI65910C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
FI773568A 1976-11-26 1977-11-24 Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan FI65910C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US74532576 1976-11-26
US80010577A 1977-05-24 1977-05-24
US80010577 1977-05-24

Publications (3)

Publication Number Publication Date
FI773568A true FI773568A (fi) 1978-05-27
FI65910B FI65910B (fi) 1984-04-30
FI65910C FI65910C (fi) 1984-08-10

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
FI773568A FI65910C (fi) 1976-11-26 1977-11-24 Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan

Country Status (21)

Country Link
JP (1) JPS609697B2 (fi)
AR (1) AR218047A1 (fi)
AT (1) AT359197B (fi)
AU (1) AU511080B2 (fi)
BE (1) BE861141A (fi)
CA (1) CA1086226A (fi)
CH (1) CH639560A5 (fi)
DE (1) DE2752728C2 (fi)
DK (1) DK150534C (fi)
FI (1) FI65910C (fi)
FR (1) FR2373288A1 (fi)
GB (1) GB1544761A (fi)
GR (1) GR61724B (fi)
IE (1) IE45998B1 (fi)
IL (1) IL53462A (fi)
LU (1) LU78584A1 (fi)
NL (1) NL182283C (fi)
NO (1) NO147626C (fi)
NZ (1) NZ185772A (fi)
PT (1) PT67323B (fi)
SE (1) SE426781B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (de) 1979-07-20 1981-02-05 Lentia Gmbh Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
EP0542926B1 (en) * 1990-08-07 1995-02-15 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
WO2019074829A1 (en) 2017-10-09 2019-04-18 Rhodes Pharmaceuticals L.P. RESINATE-BASED PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THEM

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (fi) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets

Also Published As

Publication number Publication date
FR2373288B1 (fi) 1980-06-13
JPS609697B2 (ja) 1985-03-12
NO147626C (no) 1983-05-25
ATA848077A (de) 1980-03-15
GR61724B (en) 1978-12-29
NL182283C (nl) 1988-02-16
IL53462A0 (en) 1978-01-31
CA1086226A (en) 1980-09-23
DE2752728A1 (de) 1978-06-01
NZ185772A (en) 1978-12-18
AR218047A1 (es) 1980-05-15
DK150534C (da) 1987-10-12
DK523277A (da) 1978-05-27
IE45998L (en) 1978-05-26
JPS5369822A (en) 1978-06-21
SE426781B (sv) 1983-02-14
SE7713370L (sv) 1978-05-27
DE2752728C2 (de) 1985-08-01
PT67323B (en) 1979-04-24
AU3098677A (en) 1979-05-31
IL53462A (en) 1980-12-31
AT359197B (de) 1980-10-27
BE861141A (fr) 1978-03-16
GB1544761A (en) 1979-04-25
FI65910C (fi) 1984-08-10
FI65910B (fi) 1984-04-30
NO147626B (no) 1983-02-07
PT67323A (en) 1977-12-01
CH639560A5 (en) 1983-11-30
NL182283B (nl) 1987-09-16
LU78584A1 (fi) 1978-04-20
IE45998B1 (en) 1983-01-26
NL7712996A (nl) 1978-05-30
NO774051L (no) 1978-05-29
AU511080B2 (en) 1980-07-24
FR2373288A1 (fr) 1978-07-07
DK150534B (da) 1987-03-23

Similar Documents

Publication Publication Date Title
FI801876A (fi) Farmaceutiska preparat
IT1092262B (it) Spirolattoni e procedimento per la loro preparazione
AT364675B (de) Insektizide zubereitung
FI800910A (fi) Farmaceutiskt anvaendbara 4-amino-3-kinolinkarboxylsyror och -estrar
SE7709359L (sv) Farmaceutisk doseringsform
NO152861C (no) Herbicid preparat.
SE418053B (sv) Oral beredning
NO770895L (no) Biocid preparat.
FI64230B (fi) Bromsskiva med ventilationskylning
SE7711395L (sv) Farmaceutisk komposition
NO821514L (no) Fungicid preparat
DK153811C (da) Rodenticidt praeparat
FI773568A (fi) Farmaceutiska preparat med laongtidsverkan
NO145525C (no) Rodenticid preparat
FI763506A (fi) Farmaceutisk naeringsfoerpackning
SE7713458L (sv) Kosmetiskt preparat
DK300877A (da) Pesticidt preparat
SE7608478L (sv) Farmaceutica
FI773812A (fi) Farmaceutiska foereningar
SE7512782L (sv) Forbettrad urokinasframstellning
FI781628A (fi) Foereningar av pregnanserien med en syrefunktion i 19-staellningen foerfaranden foer deras framstaellning samt farmaceutiska preparat innehaollande dessa foereningar
DK102876A (da) Insekticidholdigt preparat
DK510977A (da) Hygiejnisk-kosmetisk praeparat
FI773813A (fi) Farmaceutiska foereningar
SE7705658L (sv) Farmaceutisk komposition

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: FISONS CORPORATION